ArticleStem cell research & therapy2015

Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Dongrui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.